CYB5R4 (cytochrome b5 reductase 4)

2014-11-01  

Identity

HGNC
LOCATION
6q14.2
LOCUSID
ALIAS
NCB5OR,cb5/cb5R,dJ676J13.1
FUSION GENES

Other Information

Locus ID:

NCBI: 51167
MIM: 608343
HGNC: 20147
Ensembl: ENSG00000065615

Variants:

dbSNP: 51167
ClinVar: 51167
TCGA: ENSG00000065615
COSMIC: CYB5R4

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000065615ENST00000369679A0A0A0MRM6
ENSG00000065615ENST00000369681Q7L1T6

Expression (GTEx)

0
5
10
15

Pathways

PathwaySourceExternal ID
Amino sugar and nucleotide sugar metabolismKEGGko00520
Amino sugar and nucleotide sugar metabolismKEGGhsa00520
MetabolismREACTOMER-HSA-1430728
O2/CO2 exchange in erythrocytesREACTOMER-HSA-1480926
Erythrocytes take up carbon dioxide and release oxygenREACTOMER-HSA-1237044

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA10176rasburicaseChemicalLabelAnnotationassociated
PA450125isosorbide dinitrateChemicalLabelAnnotationassociated
PA450126isosorbide mononitrateChemicalLabelAnnotationassociated
PA450475metoclopramideChemicalLabelAnnotationassociated
PA451103primaquineChemicalLabelAnnotationassociated

References

Pubmed IDYearTitleCitations
380413942024The N-terminal intrinsically disordered region of Ncb5or docks with the cytochrome b(5) core to form a helical motif that is of ancient origin.0
380413942024The N-terminal intrinsically disordered region of Ncb5or docks with the cytochrome b(5) core to form a helical motif that is of ancient origin.0
268782592016Cytosolic localization of NADH cytochrome b₅ oxidoreductase (Ncb5or).1
268782592016Cytosolic localization of NADH cytochrome b₅ oxidoreductase (Ncb5or).1
235239302013Natural mutations lead to enhanced proteasomal degradation of human Ncb5or, a novel flavoheme reductase.7
235239302013Natural mutations lead to enhanced proteasomal degradation of human Ncb5or, a novel flavoheme reductase.7
226275752012Methemoglobin reductase deficiency: novel mutation is associated with a disease phenotype of intermediate severity.6
226275752012Methemoglobin reductase deficiency: novel mutation is associated with a disease phenotype of intermediate severity.6
206280862010Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.15
206308632010Study of the individual cytochrome b5 and cytochrome b5 reductase domains of Ncb5or reveals a unique heme pocket and a possible role of the CS domain.13
206280862010Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.15
206308632010Study of the individual cytochrome b5 and cytochrome b5 reductase domains of Ncb5or reveals a unique heme pocket and a possible role of the CS domain.13
199131212009Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.105
199131212009Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.105
151311102004NCB5OR is a novel soluble NAD(P)H reductase localized in the endoplasmic reticulum.24

Citation

Dessen P

CYB5R4 (cytochrome b5 reductase 4)

Atlas Genet Cytogenet Oncol Haematol. 2014-11-01

Online version: http://atlasgeneticsoncology.org/gene/62237/css/img/logo-atlas-4.svg